HGNC Family | Zinc fingers |
Name | tet methylcytosine dioxygenase 1 |
Description | DNA methylation is an epigenetic mechanism that is important for controlling gene expression. The protein encoded by this gene is a demethylase that belongs to the TET (ten-eleven translocation) family. Members of the TET protein family play a role in the DNA methylation process and gene activation. [provided by RefSeq, Sep 2015] |
Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nTET1 is a 2‑oxoglutarate– (2OG–) and Fe(II)–dependent dioxygenase that initiates active DNA demethylation by oxidizing 5‑methylcytosine (5mC) into 5‑hydroxymethylcytosine (5hmC), a modification critical for regulating gene expression programs in embryonic stem cells and during development. This enzymatic activity, which can be influenced by metabolic changes and mutations (for example, those affecting cofactors or downstream oxidation intermediates), sets the stage for subsequent chromatin re‐organization and promotes demethylation via mechanisms including deamination and base excision repair. Collectively, these studies underscore TET1’s fundamental role in establishing and maintaining an epigenetically permissive state at CpG‑rich regulatory elements."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn cancer, TET1 exhibits a context‑dependent duality. In many solid tumors—including colorectal, gastric, and breast cancers—a downregulation of TET1 and a loss of 5hmC are associated with hypermethylation and silencing of tumor suppressor genes (such as PTEN and inhibitors of metalloproteinases), thereby promoting increased cell proliferation, invasion, and metastasis; restoration of TET1 activity can reverse these aberrant methylation patterns and hinder tumor progression. In contrast, in MLL‑rearranged leukemias TET1 is aberrantly upregulated, where it cooperates with fusion proteins to stimulate oncogenic programs (for example, through the activation of HOXA9, MEIS1, and related targets), thereby contributing directly to leukemogenesis. These findings illustrate that whether acting as a tumor suppressor or as an oncogenic driver, TET1’s regulation of DNA methylation is a pivotal determinant in tumorigenesis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "14", "end_ref": "31"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its core demethylase function in shaping the epigenetic landscape, TET1 is dynamically regulated by environmental and intracellular signals such as hypoxia, inflammatory cytokines, and metabolic stress, which in turn modulate its impact on transcriptional networks and cell fate decisions. Hypoxic conditions, for instance, can lead to TET1 upregulation and redistribution of 5hmC to hypoxia‐responsive gene promoters, while in other cellular settings diminished TET1 levels can alter NF‑κB signaling and contribute to chemoresistance. Emerging data also implicate interactions with specific microRNAs and post‑translational modifications as additional layers controlling TET1 activity, emphasizing its broad role in genome integrity, alternative splicing regulation, and even in modulating immune responses. These multifaceted insights position TET1 as both a critical mediator of normal cellular function and a potential therapeutic target in diverse disease contexts."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "32", "end_ref": "36"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Mamta Tahiliani, Kian Peng Koh, Yinghua Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1170116"}], "href": "https://doi.org/10.1126/science.1170116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19372391"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19372391"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Wei Xu, Hui Yang, Ying Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2010.12.014"}], "href": "https://doi.org/10.1016/j.ccr.2010.12.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21251613"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21251613"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Junjie U Guo, Yijing Su, Chun Zhong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2011.03.022"}], "href": "https://doi.org/10.1016/j.cell.2011.03.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21496894"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21496894"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Omar Abdel-Wahab, Ann Mullally, Cyrus Hedvat, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2009-03-210039"}], "href": "https://doi.org/10.1182/blood-2009-03-210039"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19420352"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19420352"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yotaro Kudo, Keisuke Tateishi, Keisuke Yamamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1349-7006.2012.02213.x"}], "href": "https://doi.org/10.1111/j.1349-7006.2012.02213.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22320381"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22320381"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Miao Sun, Chun-Xiao Song, Hao Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1305172110"}], "href": "https://doi.org/10.1073/pnas.1305172110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23716660"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23716660"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Tuomas Laukka, Christopher J Mariani, Tuukka Ihantola, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M115.688762"}], "href": "https://doi.org/10.1074/jbc.M115.688762"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26703470"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26703470"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Lulu Hu, Junyan Lu, Jingdong Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural insight into substrate preference for TET-mediated oxidation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature15713"}], "href": "https://doi.org/10.1038/nature15713"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26524525"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26524525"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Hao Huang, Xi Jiang, Zejuan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TET1 plays an essential oncogenic role in MLL-rearranged leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1310656110"}], "href": "https://doi.org/10.1073/pnas.1310656110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23818607"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23818607"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Peng-Fei Zhang, Chuan-Yuan Wei, Xiao-Yong Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-019-1031-1"}], "href": "https://doi.org/10.1186/s12943-019-1031-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31153371"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31153371"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Khelifa Arab, Emil Karaulanov, Michael Musheev, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GADD45A binds R-loops and recruits TET1 to CpG island promoters."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41588-018-0306-6"}], "href": "https://doi.org/10.1038/s41588-018-0306-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30617255"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30617255"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "F Neri, D Dettori, D Incarnato, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2014.356"}], "href": "https://doi.org/10.1038/onc.2014.356"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25362856"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25362856"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Chungang Liu, Limei Liu, Xuejiao Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0062828"}], "href": "https://doi.org/10.1371/journal.pone.0062828"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23671639"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23671639"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Christopher J Mariani, Aparna Vasanthakumar, Jozef Madzo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2014.04.040"}], "href": "https://doi.org/10.1016/j.celrep.2014.04.040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24835990"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24835990"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Ya-Ping Tsai, Hsiao-Fan Chen, Sung-Yuan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genome Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13059-014-0513-0"}], "href": "https://doi.org/10.1186/s13059-014-0513-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25517638"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25517638"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "K A Kang, M J Piao, K C Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2014.149"}], "href": "https://doi.org/10.1038/cddis.2014.149"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24743738"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24743738"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Hari K Somineni, Xue Zhang, Jocelyn M Biagini Myers, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ten-eleven translocation 1 (TET1) methylation is associated with childhood asthma and traffic-related air pollution."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Allergy Clin Immunol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jaci.2015.10.021"}], "href": "https://doi.org/10.1016/j.jaci.2015.10.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26684294"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26684294"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Chunlei Jin, Yue Lu, Jaroslav Jelinek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TET1 is a maintenance DNA demethylase that prevents methylation spreading in differentiated cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gku372"}], "href": "https://doi.org/10.1093/nar/gku372"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24875481"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24875481"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Min-Zu Wu, Su-Feng Chen, Shin Nieh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia Drives Breast Tumor Malignancy through a TET-TNFα-p38-MAPK Signaling Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-14-3208"}], "href": "https://doi.org/10.1158/0008-5472.CAN-14-3208"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26294212"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26294212"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Carlos J Pirola, Romina Scian, Tomas Fernández Gianotti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Medicine (Baltimore) (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MD.0000000000001480"}], "href": "https://doi.org/10.1097/MD.0000000000001480"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26356709"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26356709"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Carina Frauer, Andrea Rottach, Daniela Meilinger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Different binding properties and function of CXXC zinc finger domains in Dnmt1 and Tet1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0016627"}], "href": "https://doi.org/10.1371/journal.pone.0016627"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21311766"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21311766"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Ryan J Marina, David Sturgill, Marc A Bailly, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TET-catalyzed oxidation of intragenic 5-methylcytosine regulates CTCF-dependent alternative splicing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15252/embj.201593235"}], "href": "https://doi.org/10.15252/embj.201593235"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26711177"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26711177"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Tao Wang, Hao Wu, Yujing Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Subtelomeric hotspots of aberrant 5-hydroxymethylcytosine-mediated epigenetic modifications during reprogramming to pluripotency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb2748"}], "href": "https://doi.org/10.1038/ncb2748"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23685628"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23685628"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "E Dong, W B Ruzicka, D R Grayson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Schizophr Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.schres.2014.10.030"}], "href": "https://doi.org/10.1016/j.schres.2014.10.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25476119"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25476119"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Emily L Putiri, Rochelle L Tiedemann, Joyce J Thompson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genome Biol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/gb-2014-15-6-r81"}], "href": "https://doi.org/10.1186/gb-2014-15-6-r81"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24958354"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24958354"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Wendong Li, E Tian, Zhao-Xia Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of Oct4-activating compounds that enhance reprogramming efficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1219181110"}], "href": "https://doi.org/10.1073/pnas.1219181110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23213213"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23213213"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Hua-Lin Fu, Yue Ma, Lun-Gen Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biomed Nanotechnol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1166/jbn.2014.1861"}], "href": "https://doi.org/10.1166/jbn.2014.1861"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24804542"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24804542"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Qi-Fei Tao, Sheng-Xian Yuan, Fu Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-015-0437-7"}], "href": "https://doi.org/10.1186/s12943-015-0437-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26376879"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26376879"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Qing Chen, Dan Yin, Yong Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2017.142"}], "href": "https://doi.org/10.1038/cddis.2017.142"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28661477"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28661477"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Jian Wu, Hongzhe Li, Minmin Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-019-1334-5"}], "href": "https://doi.org/10.1186/s13046-019-1334-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31399111"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31399111"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Lili Li, Chen Li, Haitao Mao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep26591"}], "href": "https://doi.org/10.1038/srep26591"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27225590"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27225590"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Hao-Xiang Wu, Yan-Xing Chen, Zi-Xian Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunother Cancer (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s40425-019-0737-3"}], "href": "https://doi.org/10.1186/s40425-019-0737-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31623662"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31623662"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Liu Yang, San-Jian Yu, Qi Hong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced Expression of TET1, TET2, TET3 and TDG mRNAs Are Associated with Poor Prognosis of Patients with Early Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0133896"}], "href": "https://doi.org/10.1371/journal.pone.0133896"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26207381"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26207381"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "N Shenoy, T Bhagat, E Nieves, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood Cancer J (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bcj.2017.65"}], "href": "https://doi.org/10.1038/bcj.2017.65"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28731456"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28731456"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Charly Ryan Good, Shoghag Panjarian, Andrew D Kelly, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-17-2082"}], "href": "https://doi.org/10.1158/0008-5472.CAN-17-2082"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29891505"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29891505"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Evelyne Collignon, Annalisa Canale, Clémence Al Wardi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Immunity drives "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "TET1"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " regulation in cancer through NF-κB."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Adv (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/sciadv.aap7309"}], "href": "https://doi.org/10.1126/sciadv.aap7309"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29938218"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29938218"}]}]}]}
|
Synonyms | MLL-TET1, CXXC6, LCX, BA119F7.1 |
Proteins | TET1_HUMAN |
NCBI Gene ID | 80312 |
API | |
Download Associations | |
Predicted Functions |
![]() |
Co-expressed Genes |
![]() |
Expression in Tissues and Cell Lines |
![]() |
TET1 has 6,444 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 109 datasets.
Click the + buttons to view associations for TET1 from the datasets below.
If available, associations are ranked by standardized value
Dataset | Summary | |
---|---|---|
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TET1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of TET1 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of TET1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of TET1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TET1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TET1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TET1 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of TET1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of TET1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
CCLE Cell Line Gene Mutation Profiles | cell lines with TET1 gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset. | |
CellMarker Gene-Cell Type Associations | cell types associated with TET1 gene from the CellMarker Gene-Cell Type Associations dataset. | |
ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TET1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
ChEA Transcription Factor Targets | transcription factors binding the promoter of TET1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of TET1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing TET1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing TET1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing TET1 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing TET1 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with TET1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with TET1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of TET1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
COSMIC Cell Line Gene Mutation Profiles | cell lines with TET1 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
CTD Gene-Chemical Interactions | chemicals interacting with TET1 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
CTD Gene-Disease Associations | diseases associated with TET1 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of TET1 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
DepMap CRISPR Gene Dependency | cell lines with fitness changed by TET1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with TET1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with TET1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with TET1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
DisGeNET Gene-Disease Associations | diseases associated with TET1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
DisGeNET Gene-Phenotype Associations | phenotypes associated with TET1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TET1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TET1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
ENCODE Transcription Factor Targets | transcription factors binding the promoter of TET1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing TET1 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
GAD Gene-Disease Associations | diseases associated with TET1 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
GeneRIF Biological Term Annotations | biological terms co-occuring with TET1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing TET1 from the GeneSigDB Published Gene Signatures dataset. | |
GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of TET1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TET1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of TET1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TET1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of TET1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of TET1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
GO Biological Process Annotations 2015 | biological processes involving TET1 gene from the curated GO Biological Process Annotations 2015 dataset. | |
GO Biological Process Annotations 2023 | biological processes involving TET1 gene from the curated GO Biological Process Annotations 2023 dataset. | |
GO Biological Process Annotations 2025 | biological processes involving TET1 gene from the curated GO Biological Process Annotations2025 dataset. | |
GO Cellular Component Annotations 2015 | cellular components containing TET1 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
GO Cellular Component Annotations 2023 | cellular components containing TET1 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
GO Cellular Component Annotations 2025 | cellular components containing TET1 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
GO Molecular Function Annotations 2015 | molecular functions performed by TET1 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
GO Molecular Function Annotations 2023 | molecular functions performed by TET1 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
GO Molecular Function Annotations 2025 | molecular functions performed by TET1 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
GTEx Tissue Gene Expression Profiles | tissues with high or low expression of TET1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of TET1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TET1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
GWASdb SNP-Disease Associations | diseases associated with TET1 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
GWASdb SNP-Phenotype Associations | phenotypes associated with TET1 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
HMDB Metabolites of Enzymes | interacting metabolites for TET1 protein from the curated HMDB Metabolites of Enzymes dataset. | |
HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of TET1 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
HPA Tissue Gene Expression Profiles | tissues with high or low expression of TET1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
HPA Tissue Protein Expression Profiles | tissues with high or low expression of TET1 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TET1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
HuGE Navigator Gene-Phenotype Associations | phenotypes associated with TET1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
InterPro Predicted Protein Domain Annotations | protein domains predicted for TET1 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of TET1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of TET1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of TET1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with TET1 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of TET1 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
LOCATE Curated Protein Localization Annotations | cellular components containing TET1 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain TET1 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by TET1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
MiRTarBase microRNA Targets | microRNAs targeting TET1 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of TET1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of TET1 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by TET1 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of TET1 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
MW Enzyme Metabolite Associations | interacting metabolites for TET1 protein from the MW Gene Metabolite Associations dataset. | |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of TET1 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
NURSA Protein Complexes | protein complexs containing TET1 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
Pathway Commons Protein-Protein Interactions | interacting proteins for TET1 from the Pathway Commons Protein-Protein Interactions dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TET1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of TET1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
PFOCR Pathway Figure Associations 2023 | pathways involving TET1 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
PFOCR Pathway Figure Associations 2024 | pathways involving TET1 protein from the Wikipathways PFOCR 2024 dataset. | |
Reactome Pathways 2014 | pathways involving TET1 protein from the Reactome Pathways dataset. | |
Reactome Pathways 2024 | pathways involving TET1 protein from the Reactome Pathways 2024 dataset. | |
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of TET1 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of TET1 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of TET1 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of TET1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TET1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TET1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of TET1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of TET1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs | drug perturbations changing phosphorylation of TET1 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset. | |
Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of TET1 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of TET1 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of TET1 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of TET1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of TET1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of TET1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TET1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TET1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with TET1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with TET1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
WikiPathways Pathways 2014 | pathways involving TET1 protein from the Wikipathways Pathways 2014 dataset. | |
WikiPathways Pathways 2024 | pathways involving TET1 protein from the WikiPathways Pathways 2024 dataset. | |